Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 6
1998 1
2000 5
2001 2
2002 6
2003 11
2004 3
2005 3
2006 4
2009 3
2010 1
2011 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Mild cognitive impairment as a diagnostic entity.
Petersen RC. Petersen RC. J Intern Med. 2004 Sep;256(3):183-94. doi: 10.1111/j.1365-2796.2004.01388.x. J Intern Med. 2004. PMID: 15324362 Free article. Review.
Memantine in moderate-to-severe Alzheimer's disease.
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group. Reisberg B, et al. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128. N Engl J Med. 2003. PMID: 12672860 Free article. Clinical Trial.
Chronic divalproex sodium use and brain atrophy in Alzheimer disease.
Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study. Fleisher AS, et al. Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14. Neurology. 2011. PMID: 21917762 Free PMC article. Clinical Trial.
Recent developments in Alzheimer's disease therapeutics.
Rafii MS, Aisen PS. Rafii MS, et al. BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. BMC Med. 2009. PMID: 19228370 Free PMC article. Review.
Mild cognitive impairment clinical trials.
Petersen RC. Petersen RC. Nat Rev Drug Discov. 2003 Aug;2(8):646-53. doi: 10.1038/nrd1155. Nat Rev Drug Discov. 2003. PMID: 12904814 Review. No abstract available.
NSAIDs and hypertension.
Aisen PS, Schafer K, Grundman M, Thomas R, Thal LJ. Aisen PS, et al. Arch Intern Med. 2003 May 12;163(9):1115; author reply 1115-6. doi: 10.1001/archinte.163.9.1115-a. Arch Intern Med. 2003. PMID: 12742818 No abstract available.
Antioxidant strategies for Alzheimer's disease.
Grundman M, Grundman M, Delaney P. Grundman M, et al. Proc Nutr Soc. 2002 May;61(2):191-202. doi: 10.1079/PNS2002146. Proc Nutr Soc. 2002. PMID: 12133201 Review.
Mild cognitive impairment as a clinical entity and treatment target.
Petersen RC, Morris JC. Petersen RC, et al. Arch Neurol. 2005 Jul;62(7):1160-3; discussion 1167. doi: 10.1001/archneur.62.7.1160. Arch Neurol. 2005. PMID: 16009779 Review. No abstract available.
Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
Wynn ZJ, Cummings JL. Wynn ZJ, et al. Dement Geriatr Cogn Disord. 2004;17(1-2):100-8. doi: 10.1159/000074281. Epub 2003 Oct 15. Dement Geriatr Cogn Disord. 2004. PMID: 14564129 Review.
Aging, mild cognitive impairment, and Alzheimer's disease.
Petersen RC. Petersen RC. Neurol Clin. 2000 Nov;18(4):789-806. doi: 10.1016/s0733-8619(05)70226-7. Neurol Clin. 2000. PMID: 11072261 Review.
47 results
Jump to page
Feedback